State Board of Administration of Florida Retirement System grew its stake in 1Life Healthcare, Inc. (NASDAQ:ONEM – Get Rating) by 23.8% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 41,944 shares of the company’s stock after purchasing an additional 8,050 shares during the quarter. State Board of Administration of Florida Retirement System’s holdings in 1Life Healthcare were worth $329,000 as of its most recent filing with the SEC.
Several other large investors have also modified their holdings of the stock. Tiger Global Management LLC increased its holdings in 1Life Healthcare by 28.1% in the first quarter. Tiger Global Management LLC now owns 17,673,234 shares of the company’s stock valued at $195,819,000 after buying an additional 3,880,134 shares during the last quarter. Addition Three General Partner L.P. raised its position in shares of 1Life Healthcare by 27.3% during the 1st quarter. Addition Three General Partner L.P. now owns 9,107,802 shares of the company’s stock valued at $100,914,000 after acquiring an additional 1,954,000 shares in the last quarter. Janney Montgomery Scott LLC acquired a new stake in shares of 1Life Healthcare during the 2nd quarter valued at approximately $6,604,000. Vanguard Group Inc. lifted its stake in 1Life Healthcare by 2.3% during the first quarter. Vanguard Group Inc. now owns 14,448,803 shares of the company’s stock worth $160,092,000 after purchasing an additional 324,722 shares during the last quarter. Finally, State of New Jersey Common Pension Fund D acquired a new position in 1Life Healthcare in the first quarter worth $2,944,000. Institutional investors own 79.58% of the company’s stock.
Analysts Set New Price Targets
A number of analysts have weighed in on ONEM shares. Truist Financial cut shares of 1Life Healthcare from a “buy” rating to a “hold” rating and set a $18.00 target price on the stock. in a report on Monday, July 25th. Jefferies Financial Group cut shares of 1Life Healthcare from a “buy” rating to a “hold” rating and raised their target price for the stock from $12.00 to $18.00 in a report on Monday, August 15th. Evercore ISI upped their target price on 1Life Healthcare to $18.00 in a report on Tuesday, August 9th. Stifel Nicolaus downgraded 1Life Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, July 27th. Finally, Credit Suisse Group downgraded 1Life Healthcare from an “outperform” rating to a “neutral” rating and set a $18.00 price target on the stock. in a report on Thursday, October 27th. Thirteen analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, 1Life Healthcare has an average rating of “Hold” and a consensus price target of $17.27.
1Life Healthcare Stock Down 0.2 %
1Life Healthcare (NASDAQ:ONEM – Get Rating) last announced its earnings results on Wednesday, November 2nd. The company reported ($0.57) earnings per share for the quarter, missing the consensus estimate of ($0.38) by ($0.19). 1Life Healthcare had a negative net margin of 39.15% and a negative return on equity of 23.82%. The business had revenue of $261.37 million for the quarter, compared to the consensus estimate of $273.51 million. During the same period in the previous year, the firm earned ($0.51) EPS. The firm’s revenue was up 72.7% on a year-over-year basis. As a group, research analysts forecast that 1Life Healthcare, Inc. will post -1.96 EPS for the current year.
In other news, CFO Bjorn B. Thaler sold 325,575 shares of 1Life Healthcare stock in a transaction on Tuesday, October 4th. The stock was sold at an average price of $17.18, for a total transaction of $5,593,378.50. Following the transaction, the chief financial officer now directly owns 1,869 shares in the company, valued at approximately $32,109.42. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, CEO Amir Dan Rubin sold 2,123,402 shares of 1Life Healthcare stock in a transaction on Wednesday, October 5th. The stock was sold at an average price of $17.09, for a total transaction of $36,288,940.18. Following the transaction, the chief executive officer now directly owns 99,748 shares in the company, valued at approximately $1,704,693.32. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CFO Bjorn B. Thaler sold 325,575 shares of 1Life Healthcare stock in a transaction on Tuesday, October 4th. The shares were sold at an average price of $17.18, for a total value of $5,593,378.50. Following the transaction, the chief financial officer now owns 1,869 shares in the company, valued at $32,109.42. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 4,274,827 shares of company stock worth $73,009,522. 4.40% of the stock is owned by company insiders.
1Life Healthcare Company Profile
1Life Healthcare, Inc operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs.
- Get a free copy of the StockNews.com research report on 1Life Healthcare (ONEM)
- Is GameStop Stock Setting Up for Another Short Squeeze?
- Here’s Why SoFi Technologies Stock is Cheap at These Levels
- Warren Buffet Bought Taiwan Semiconductor Stock, Should You?
- MarketBeat: Week in Review 11/14 – 11/18
- Target’s Double Bottom Might Have Just Been Confirmed
Receive News & Ratings for 1Life Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 1Life Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.